One of the most intriguing outcomes was that through trans-activating ICAT, E2F1 could negatively regulate Wnt/β-catenin activity, whose aberrant activation contributes to cell growth, tissue invasion and metastasis of CRC [18,19]. Here, E2F1 is linked to colorectal carcinoma.